Literature DB >> 32298219

Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines.

Priya Pereira1, Bernd Benninghoff1, Leentje Moerman1.   

Abstract

This study is aimed to review the published evidence on safety, immunogenicity, and efficacy of rotavirus vaccines when co-administered with meningococcal vaccines in infants. A systematic literature search was performed in four databases containing peer-reviewed articles and conference abstracts. In total, twelve articles were included in the review; 11 provided information on safety and five on the immunogenicity of rotavirus vaccines following co-administration. No paper was found on efficacy. Additional routine vaccines were administered in all studies. The safety analysis was mainly focused on fever, vomiting, diarrhea, intussusception, and changes in eating habits. Overall, safety profiles and immune responses associated with rotavirus vaccination were comparable between infants co-administered with rotavirus and meningococcal vaccines and infants receiving rotavirus vaccines without meningococcal vaccines. Although data are limited, co-administration of rotavirus and meningococcal vaccines does not appear to interfere with the safety or immunogenicity of rotavirus vaccines.

Entities:  

Keywords:  Neisseria meningitidis ; Rotavirus; co-administration; immunogenicity; infants; meningococcal vaccines; safety; systematic literature review

Year:  2020        PMID: 32298219      PMCID: PMC7746238          DOI: 10.1080/21645515.2020.1739485

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  23 in total

1.  Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe.

Authors:  Timo Vesikari; Aino Karvonen; Roman Prymula; Volker Schuster; Juan C Tejedor; Franck Thollot; Pilar Garcia-Corbeira; Silvia Damaso; Htay-Htay Han; Alain Bouckenooghe
Journal:  Vaccine       Date:  2010-06-09       Impact factor: 3.641

Review 2.  Effect of vaccine administration modality on immunogenicity and efficacy.

Authors:  Lu Zhang; Wei Wang; Shixia Wang
Journal:  Expert Rev Vaccines       Date:  2015-08-27       Impact factor: 5.217

3.  Safety and immunogenicity of a novel quadrivalent meningococcal CRM-conjugate vaccine given concomitantly with routine vaccinations in infants.

Authors:  Nicola P Klein; Keith S Reisinger; William Johnston; Tatjana Odrljin; Christopher J Gill; Lisa Bedell; Peter Dull
Journal:  Pediatr Infect Dis J       Date:  2012-01       Impact factor: 2.129

Review 4.  The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines.

Authors:  Stephen I Pelton
Journal:  J Adolesc Health       Date:  2016-08       Impact factor: 5.012

Review 5.  A systematic review of factors affecting vaccine uptake in young children.

Authors:  Louise E Smith; Richard Amlôt; John Weinman; Jenny Yiend; G James Rubin
Journal:  Vaccine       Date:  2017-09-30       Impact factor: 3.641

Review 6.  The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection.

Authors:  Ray Borrow; Pedro Alarcón; Josefina Carlos; Dominique A Caugant; Hannah Christensen; Roberto Debbag; Philippe De Wals; Gabriela Echániz-Aviles; Jamie Findlow; Chris Head; Daphne Holt; Hajime Kamiya; Samir K Saha; Sergey Sidorenko; Muhamed-Kheir Taha; Caroline Trotter; Julio A Vázquez Moreno; Anne von Gottberg; Marco A P Sáfadi
Journal:  Expert Rev Vaccines       Date:  2016-11-22       Impact factor: 5.217

7.  Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

Review 8.  A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program.

Authors:  Miguel O'Ryan; Jeffrey Stoddard; Daniela Toneatto; James Wassil; Peter M Dull
Journal:  Drugs       Date:  2014-01       Impact factor: 9.546

9.  Immunogenicity and safety of the Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine co-administered with human rotavirus, hepatitis A and 13-valent pneumococcal conjugate vaccines: results from a phase III, randomized, multicenter study in infants.

Authors:  Nicola P Klein; Remon Abu-Elyazeed; Yaela Baine; Brigitte Cheuvart; Marcela Silerova; Narcisa Mesaros
Journal:  Hum Vaccin Immunother       Date:  2018-10-05       Impact factor: 3.452

Review 10.  Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination.

Authors:  Cynthia Burman; Lidia Serra; Charles Nuttens; Jessica Presa; Paul Balmer; Laura York
Journal:  Hum Vaccin Immunother       Date:  2018-10-29       Impact factor: 3.452

View more
  2 in total

1.  Effectiveness of "Priorix" Against Measles and Mumps Diseases in Children Born After 2004 in the United Kingdom: A Retrospective Case-control Study Using the Clinical Practice Research Datalink GOLD Database.

Authors:  Michael Povey; Emmanuel Aris; Brigitte Cheuvart; Gillian Hall; Catherine Cohet; Corinne Willame
Journal:  Pediatr Infect Dis J       Date:  2021-06-01       Impact factor: 2.129

2.  Rotavirus vaccine administration patterns in Italy: potential impact on vaccine coverage, compliance and adherence.

Authors:  Domenico Martinelli; Francesca Fortunato; Federico Marchetti; Rosa Prato
Journal:  Hum Vaccin Immunother       Date:  2020-09-18       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.